Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.
Benedetti Panici P, Pierelli L, Scambia G, Foddai ML, Salerno MG, Menichella G, Vittori M, Maneschi F, Caracussi U, Serafini R, Leone G, Mancuso S. Benedetti Panici P, et al. Among authors: scambia g. Br J Cancer. 1997;75(8):1205-12. doi: 10.1038/bjc.1997.206. Br J Cancer. 1997. PMID: 9099971 Free PMC article. Clinical Trial.
Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison.
Pierelli L, Perillo A, Greggi S, Salerno G, Panici PB, Menichella G, Fattorossi A, Leone G, Mancuso S, Scambia G. Pierelli L, et al. Among authors: scambia g. J Clin Oncol. 1999 Apr;17(4):1288. doi: 10.1200/JCO.1999.17.4.1288. J Clin Oncol. 1999. PMID: 10561191 Clinical Trial.
Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF.
Perillo A, Pierelli L, Scambia G, Serafini R, Paladini U, Salerno MG, Bonanno G, Fattorossi A, Leone G, Mancuso S, Menichella G. Perillo A, et al. Among authors: scambia g. Transfusion. 2001 May;41(5):674-80. doi: 10.1046/j.1537-2995.2001.41050674.x. Transfusion. 2001. PMID: 11346705 Clinical Trial.
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF.
Pierelli L, Perillo A, Ferrandina G, Salerno G, Rutella S, Fattorossi A, Battaglia A, Rughetti A, Nuti M, Cortesi E, Leone G, Mancuso S, Scambia G. Pierelli L, et al. Among authors: scambia g. Transfusion. 2001 Dec;41(12):1577-85. doi: 10.1046/j.1537-2995.2001.41121577.x. Transfusion. 2001. PMID: 11778075 Clinical Trial.
2,091 results